Chemistry: analytical and immunological testing – Biological cellular material tested
Patent
1985-11-13
1989-09-05
Richman, Barry S.
Chemistry: analytical and immunological testing
Biological cellular material tested
73 611C, 204 1T, 204411, 204412, 422 70, 436 68, 436150, 436161, 436175, G01N 2750
Patent
active
048638730
ABSTRACT:
A method for establishing a treatment protocol for correcting an abnormal condition of disease in a living organism is described. The method comprises the steps of analyzing body fluids from normal and abnormal individuals to generate analysis patterns of the normal and abnormal fluids, comparing the patterns to determine differences in the patterns, and establishing a treatment protocol for the abnormal individual through chemical or metabolic therapy which treating will normalize the abnormal pattern.
REFERENCES:
patent: 3922205 (1975-11-01), McLean et al.
patent: 4233031 (1980-11-01), Matson et al.
patent: 4404065 (1980-09-01), Matson
patent: 4511659 (1985-04-01), Matson
Blank; Dual Electrochemical Detector for Liquid Chromatography; J. of Chrom. 117 (1976) pp. 35-46.
Clinical Chemistry (Winston-Salem), 30 (9), pp. 1477-1488, issued 1984, Matson et al., "n Electrode Three-Dimensional Liquid Chromatography with Electrochemical Detection for Determination of Neurotransmitters".
Journal of Liquid Chromatography, 6(2), pp. 375-381, issued 1983, Yamaguchi, "Liquid Chromatographic Determination of Excretion Patterns of Urinary Phenolic Compounds".
Biological Markers in Psychiatry and Neurology, Proceedings of a Conference at Ochsner Clinic, New Orleans (1982), Schildkrant, "Biochemical Discrimination of Subgroups of Depressive Disorders Based on Differences in Catecholamine Metabolism", pp. 23-33.
La Nouvelle Presse Medicale, 9, pp. 2061-2063, issued 1908, Devynck et al., "Dosage Rapide des Catecholamines Plasmatiques pour le Diagnostic d'Urgence des Pheochromocytomes".
Journal of Clinical Endocrinology & Metabolism, 50 (5), pp. 857-861, issued 1980, Guliner et al, "Correction of Increased Sympathodrenal Activity in Bartter's Syndrome by Inhibition of Prostaglandin Synthesis".
Archives of General Phychiatry, 35, pp. 1427-1433, issued 1978, Schildkraut et al., "Toward a Biochemical Diagnosis & Treatment of Heroin Addiction".
Clinical Pharmacology & Therapeutics, 7(6), pp. 727-739, issued 1966, Anton et al., "The Effect of Reserpine on Catecholamine Metabolism & Behavior in Retarded Children".
Psychopharmacology, N.Y., pp. 275-328, issued 1976, Schildkraut et al., "Biochemistry of Effective Disorders", (CA85 (25) 190161d.
Neuroregul. Psychiatr. Disord., Proc. Conf. 1976, pp. 122-128, issued 1977, Schildkraut et al., "Recent Studies on Role of Catecholamines in the Pathophysiology & Classification of Depressive Orders", (CA88(9) 10675a.
Psychopharmacology (Berlin), 56(3), pp. 327-333, issued 1978, Schildkraut et al., "Opiates, Catecholamines, Behavior & Mood", CA89(7) 53498n.
Journal of American Geriatric Society, 25(7), pp. 289-298, issued Jul. 1977, Meyer et al., "Neurotransmitter Precursor Amino Acids in the Treatment of Multi-Infarct Dementia & Alzheimer's Disease", Index Medicus Journal Announcement: 7709.
Esa Inc.
McMahon Timothy M.
Richman Barry S.
LandOfFree
Method for biological testing and/or developing pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for biological testing and/or developing pharmaceuticals , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for biological testing and/or developing pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-243244